Индексировано в
  • База данных академических журналов
  • Open J Gate
  • Журнал GenamicsSeek
  • ЖурналTOCs
  • Китайская национальная инфраструктура знаний (CNKI)
  • Шимаго
  • Справочник периодических изданий Ульриха
  • RefSeek
  • Университет Хамдарда
  • ЭБСКО АЗ
  • OCLC- WorldCat
  • Паблоны
  • МИАР
  • Комиссия по университетским грантам
  • Женевский фонд медицинского образования и исследований
  • Евро Паб
  • Google Scholar
Поделиться этой страницей

Абстрактный

Potency/Immunogenicity Profile of DPT Vaccines Used in the Expanded Programme on Immunization in South-East, Nigeria

Oli AN, Agu RU, Nnadozie OJ and Esimone CO

Objectives: This study tries to validate the DPT vaccines used in South-east Nigeria for the routine childhood immunization. Study design: The Antibody Induction Method in mice was used. The neutralizing IgG antibody titers in a control group (7 mice given DPT stored at 37°C for 1 year) and test group (7 mice given DPT vaccines from the South- Eastern States of Nigeria) were compared after 30 days post-immunization using One-Way ANOVA, Bartlett’s test for equal variances and Dunnett’s Multiple Comparison Test. Results: The vaccines from the States produced similar Pertussis and Tetanus antibody titers which were significantly higher than the control (P<0.0001). The Diphtheria antibody titer produced by the vaccine from Enugu/ Ebonyi States was higher than the vaccines from other States. The control produced much less Diphtheria IgG antibody titer (P<0.0001). The vaccines do not differ significantly from each other on the level of antibody titer (protection) and their individual protection can last for the maximum number of days needed for a repeat vaccination except for the control. Conclusions: There is statistical difference in the antibody titer evoked by the control compared to that evoked by the vaccines from the states. The vaccines from the States show 100% potency and immunogenicity. This indicates adequate cold-chain maintenance and monitoring of South-eastern Nigeria. Continuous monitoring of efficiency of cold- chain maintenance and vaccine potency testing would translate to good vaccine strategy.

Отказ от ответственности: Этот реферат был переведен с помощью инструментов искусственного интеллекта и еще не прошел проверку или верификацию